Slabodkin Profile Banner
Greg Slabodkin Profile
Greg Slabodkin

@Slabodkin

Followers
3K
Following
0
Media
101
Statuses
10K

Editor in Chief @PharmaMfg #pharmamanufacturing #biopharma #CDMO #pharma #biotech #biomanufacturing #contractmanufacturing

Joined August 2009
Don't wanna be here? Send us removal request.
@Slabodkin
Greg Slabodkin
2 days
#Manufacturing and #supplychain risks in 2026 will continue to weigh on #lifesciences. The sector needs local resilience and flexibility in a complex global landscape, finds two separate reports from consulting firms #Deloitte and #WestMonroe. https://t.co/CbVcwxw03n #AI #tariffs
Tweet card summary image
pharmamanufacturing.com
The industry requires local resilience and flexibility in a complex global landscape, according to separate reports from consulting firms Deloitte and West Monroe.
0
0
0
@Slabodkin
Greg Slabodkin
3 days
#MarchesiniGroup and AST to expand aseptic #fillfinish #manufacturing. The companies are looking to strengthen their sterile drug product manufacturing portfolios through the integration of fill-finish and #packaging technologies. https://t.co/vidWAisk0l #pharmamanufacturing
Tweet card summary image
pharmamanufacturing.com
The agreement reportedly will strengthen both companies’ sterile drug product manufacturing portfolios through the integration of fill-finish and packaging technologies.
0
0
1
@Slabodkin
Greg Slabodkin
3 days
#BoraPharmaceuticals and #CorealisPharma team to streamline oral #soliddose development. The alliance connects early development expertise with commercial-scale OSD #manufacturing for a single path from formulation to market. https://t.co/eCG1bFkiqj #CDMO #pharmamanufacturing
Tweet card summary image
pharmamanufacturing.com
The alliance connects early development expertise with commercial-scale OSD manufacturing for a single path from formulation to market.
0
0
0
@Slabodkin
Greg Slabodkin
3 days
#EliLilly plans to invest $6 billion in a new active #pharmaceutical ingredient #manufacturing facility in #Alabama. The API site in Huntsville will produce #smallmolecule synthetic and #peptide medicines, including Lilly's oral #GLP1 #orforglipron.
Tweet card summary image
pharmamanufacturing.com
The Huntsville active pharmaceutical ingredient site will produce small molecule synthetic and peptide medicines, including Lilly's oral GLP-1 orforglipron.
0
0
1
@Slabodkin
Greg Slabodkin
4 days
#CellularOrigins nabs $40 million in #financing to expand its #robotic #celltherapy #manufacturing platform. The funds will support the expansion of commercial operations, integration of additional units, and development of manufacturing infrastructure.
Tweet card summary image
pharmamanufacturing.com
Investment will support the expansion of commercial operations, integration of additional units, and development of manufacturing infrastructure.
0
0
1
@Slabodkin
Greg Slabodkin
4 days
#Hovione's Christoph Brücher and #Microinnova's Dirk Kirschneck discuss in #podcast their efforts to advance #flowchemistry and #continuousmanufacturing. The collaboration looks to unlock multi-purpose capabilities to accelerate #smallmolecule production.
0
0
1
@Slabodkin
Greg Slabodkin
4 days
#Ardena's US expansion positions it for growth amid geopolitical uncertainty. The #CDMO earlier this year purchased a #Catalent drug product #manufacturing facility in #NewJersey, which was in the works before Trump's talk of #pharmatariffs and #onshoring.
Tweet card summary image
pharmamanufacturing.com
The company earlier this year purchased a Catalent drug product manufacturing facility in Somerset, New Jersey, securing its first footprint in the United States.
0
0
0
@Slabodkin
Greg Slabodkin
5 days
#HP and #mAbxience join forces to use #AI to optimize #biologics manufacturing. The collaboration centers on a #digitaltwin system built to improve predictability and efficiency in large-scale #monoclonalantibody production. https://t.co/1TS2PWvebn #biosimilars #biomanufacturing
Tweet card summary image
pharmamanufacturing.com
The collaboration centers on a digital twin system built to improve predictability and efficiency in large-scale monoclonal antibody production.
0
0
0
@Slabodkin
Greg Slabodkin
8 days
#SCTbio and #Fortrea have teamed to streamline #cellandgenetherapy development. The #CDMO-#CRO collaboration aims to accelerate advanced therapy programs from early development to commercialization. https://t.co/wiFuSogLZo #GMP #celltherapy #viralvectors #CDMOs #CROs #apheresis
Tweet card summary image
pharmamanufacturing.com
The CDMO-CRO collaboration aims to accelerate advanced therapy programs from early development to commercialization.
0
0
1
@Slabodkin
Greg Slabodkin
8 days
#QuotientSciences and #IntrepidLabs partner to advance use of #AI in early #drugdevelopment. Under the agreement, Quotient has access to Intrepid's #machinelearning model which supports rapid exploration of formulation options. https://t.co/4yuXQcpyxH #artificialintelligence
Tweet card summary image
pharmamanufacturing.com
The multi-year agreement provides access to Intrepid’s machine learning platform to support early-stage formulation decisions.
0
0
0